Clinical Trials in North Carolina

Showing 7161-7180 of 20,428 trials

Phase II Short-term Adjuvant Therapy and Biomarker Studies With Targeted Agents in Women With Estrogen Receptor Negative Breast Cancer

NCT01471106

The goal of this clinical research study is to learn if dasatinib can help prevent breast cancer from developing in the unaffected breast. Dasatinib is designed to decrease the activity of one or more proteins that are responsible for the uncontrolled growth of tumor cells. This is an investigational study. Dasatinib is FDA approved and commercially available for the treatment of leukemia. Its use in breast cancer patients in investigational. Up to 66 patients will take part in this multicenter study. Up to 60 will be enrolled at MD Anderson.

Breast Cancer

M.D. Anderson Cancer Center26 participantsStarted Jan 2014

Durham, North Carolina, United States • Houston, Texas, United States

COMPLETED57 miles

TARGET Post-Approval Study

NCT02800863

The purpose of this prospective, multicenter, single arm post-approval study is to demonstrate continued safety of the Axium and Proclaim Neurostimulator System for dorsal root ganglion (DRG) stimulation. The primary endpoint is the 12-month serious adverse event rate for permanent implants.

Complex Regional Pain Syndrome (CRPS)

Abbott Medical Devices426 participantsStarted Aug 2016

Scottsdale, Arizona, United States • Camarillo, California, United States • Larkspur, California, United States +41 more locations

Phase II Short-term Adjuvant Therapy and Biomarker Studies With Targeted Agents in Women With Estrogen Receptor Negative Breast Cancer

TARGET Post-Approval Study

Find Trials by Condition in North Carolina

Study to Evaluate the Performance and Safety of Expedial and Compare it to Expanded Polytetrafluoroethylene (ePTFE) Vascular Access Grafts

A Study of XmAb®23104 in Subjects With Selected Advanced Solid Tumors (DUET-3)

Filgotinib in Long-Term Extension Study of Adults With Crohn's Disease

Safety and Efficacy of Piromelatine in Mild Alzheimer's Disease Patients (ReCOGNITION)

Ambispective Clinical Evaluation of Sophono™

Leidos-Enabled Adaptive Protocol (LEAP-CT) for Evaluation of Post-exposure Prophylaxis for Newly-infected COVID-19 Patients

Confirmation of Diet as a Treatment for Gulf War Illness

Efficacy and Safety of HPN-100 for the Treatment of Adults With Urea Cycle Disorders

Clinical Evaluation of the FilmArray® Global Fever (GF) Panel

A Study to Find Out How Nintedanib is Taken up in the Body and How Well it is Tolerated in Children and Adolescents With Interstitial Lung Disease (ILD)

Suicide Treatment Alternatives for Teens

A Study of Ixazomib+Daratumumab+Dexamethasone (IDd) in Relapsed and/or Refractory Multiple Myeloma (RRMM)

Mass Accumulation Rate (MAR) as a Predictive Biomarker in Multiple Myeloma

CNS Penetration, PK and PD of Preoperative CC-90010 in Progressive/Recurrent Diffuse Astrocytoma, Anaplastic Astrocytoma and Glioblastoma

IPG Replacement Study (PREFERENCE-H)

A Study to Evaluate Safety and Efficacy of AMB-05X Injections in Subjects With TGCT

Study of AMG 160 in Subjects With Non-Small Cell Lung Cancer

Short-term Preoperative Treatment With Enzalutamide, Alone or in Combination With Exemestane in Primary Breast Cancer